Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and atrial electrophysiologic properties

Cardiovascular Research

Volumn 37, Issue 3, 1998, Pages 627-635

  Nattel, Stanley ^a   Lili, Liu ^a   St Georges, Dalie ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antiarrhythmic agents; Cardiac arrhythmias; ECG; Potassium channel blockers

Indexed keywords

AZIMILIDE; DOFETILIDE; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; EPICARDIUM MAPPING; HEART ATRIUM FIBRILLATION; HEART CONDUCTION; NONHUMAN; PRIORITY JOURNAL; SINUS NODE CONDUCTION VELOCITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; DOGS; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART RATE; IMIDAZOLES; IMIDAZOLIDINES; MALE; PHENETHYLAMINES; PIPERAZINES; POTASSIUM CHANNEL BLOCKERS; SULFONAMIDES;

EID: 0032029143     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00252-6     Document Type: Article

References (32)

1. [1] Nattel S, Hadjis T, Talajic M. The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 1994;48:345-371.
2. [2] Jurkiewicz NK, Sanguinetti MC. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Circ Res 1993;72:75-83.
3. KS in guinea pig cardiac myocytes. Biochem Biophys Res Comm 1994;202:265-270.
4. [4] Conder ML, Smith MA, Atwal KS, McCullough JR. Effects of NE-10064 on K+ currents in cardiac cells (abstract). Biophys J 1994;66:A326.
5. [5] Fermini B, Jurkiewicz NK, Jow B, et al. Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents. J Cardiovasc Pharmacol 1995;26:259-271.
6. [6] Yao JA, Tseng GN. Azimilide (NE-10064) can prolong or shorten the action potential duration in canine ventricular myocytes: dependence on blockage of K, Ca and Na channels. J Cardiovasc Electrophysiol 1997;8:184-198.
7. [7] Black SC, Butterfield JL, Lucchesi BR. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug. J Cardiovasc Pharmacol 1993;22:810-818.
8. [8] Drexler AP, Micklas JM, Brooks RR. Suppression of inducible ventricular arrhythmias by intravenous azimilide in dogs with previous myocardial infarction. J Cardiovasc Pharmacol 1996;28:848-855.
9. [9] Brooks RR, Carpenter JF, Miller KE, Maynard AE. Efficacy of the class III antiarrhythmic agent azimilide in rodent models of entricular arrhythmia. Proc Soc Exp Biol Med 1996;212:84-93.
10. [10] Restivo M, Hegazy M, Caref EB, et al. Effects of azimilide dihydrochloride on circus movement atrial flutter in the canine sterile pericarditis model. J Cardiovasc Electrophysiol 1996;7:612-624.
11. Ks) on canine atrial flutter (abstract). PACE 1994;17:777.
12. [12] Wang Z, Pagé P, Nattel S. The mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71:271-287.
13. [13] Wang J, Bourne GW, Wang Z, Villemaire C, Talajic M, Nattel S. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation 1993;88:1030-1044.
14. [14] Wang J, Feng J, Nattel S. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide. Circulation 1994;90:2032-2040.
15. [15] St-Georges D, Matthews C, Nattel S. A continuous maintenance infusion technique for stable anesthesia with alpha-chloralose in the dog. Contemporary Topics in Laboratory Animal Science 1997;36:62-65.
16. [16] Wang Z, Feng J, Nattel S. Idiopathic atrial fibrillation in dogs: electrophysiologic determinants and mechanisms of antiarrhythmic action of flecainide. J Am Coll Cardiol 1995;26:277-286.
17. [17] Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am J Physiol 1997;273:H805-H816.
18. [18] Nattel S, Jing W. Rate-dependent changes in intraventricular conduction produced by procainamide in anesthetized dogs: A quantitative analysis based on the relation between phase 0 inward current and conduction velocity. Circ Res 1989;65:1485-1498.
19. [19] Rensma PL, Allessie MA, Lammers WJEP, Bonke FIM, Schalij MJ. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res 1988;62:395-410.
20. [20] Ortiz J, Niwano S, Abe H, Rudy Y, Johnson NJ, Waldo AL. Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter. Insights into mechanisms. Circ Res 1994;74:882-894.
21. [21] Zhang ZH, Boutjdir M, Brooks R, Chen L, El-Sherif N. Characterization of azimilide effects on ion currents of the repolarization phase (abstract). Biophys J 1995;68:A111.
22. [22] Davies MP, Freeman LC, Kass RS. Dual actions of the novel class III antiarrhythmic drug NE-10064 on delayed potassium channel currents in guinea pig ventricular and sinoatrial node cells. J Pharmacol Exp Ther 1996;276:1149-1154.
23. [23] Carmeliet E. Voltage-and time-dependent block of the delayed K + current in cardiac myocytes by dofetilide. J Pharmacol Exp Ther 1992;262:809-817.
24. [24] Kiehn J, Villena P, Beyer T, Brachmann J. Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytes. J Cardiovasc Pharmacol 1994;24:566-572.
25. [25] Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current. J Gen Physiol 1990;96:195-215.
26. [26] Zhang Z, Follmer CH, Sarma JSM, Chen F, Singh BN. Effect of ambasilide, a new class III agent, on plateau currents in isolated guinea pig ventricular myocytes: Block of delayed outward potassium current. J Pharmacol Exp Ther 1992;263:40-48.
27. [27] Yue L, Feng J, Li GR, Nattel S. Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods. Am J Physiol 1996;270:H2157-H2168. (Heart Circ Physiol 39).
28. [28] Wang Z, Fermini B, Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res 1994;28:1540-1546.
29. [29] Tieleman RG, De Langen GDJ, Van Gelder IC, de Kam PJ, Grandjean J, Bel KJ, Wijffels MCEF, Allessie MA, Crijns HJGM. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-1953.
30. [30] Sanguinetti MC, Jurkiewicz NK. Delayed rectifier outward K+ current is composed of two currents in guinea pig atrial cells. Am J Physiol 1991;260:H393-H399. (Heart Circ Physiol 29).
31. [31] Nattel S, Bourne G, Talajic M. Insights into mechanisms of antiarrhythmic drug action from experimental models of atrial fibrillation. J Cardiovasc Electrophysiol 1997;8:469-480.
32. [32] Wade-Whittaker F, Sansone DL, Erickson BK. Rate-dependent effects of azimilide (AZ) and dofetilide (DO) on cardiac refractoriness in the ferret. FASEB J 1996;10:A64. (Abstract).